Abstract
Compared with urgent and late endoscopy among patients who have received therapeutic endoscopies, early endoscopy was associated with superior outcomes especially among patients with non-variceal bleeding. This supports the notion that non-variceal AUGIB patients should receive endoscopy within 24 hours, but also emphasises the importance of prior resuscitation and pharmacotherapy.
Introduction
Acute upper gastrointestinal bleeding (AUGIB), typically resulting from peptic ulcers or esophageal varices, remains a critical medical emergency. While clinical guidelines generally advocate for endoscopy within 24 hours of admission, the optimal timing within this window is debated. Some clinicians push for "urgent" intervention (under 6 hours) to halt hemorrhage immediately, while others argue that rushing prevents necessary hemodynamic stabilization. This territory-wide study investigates the "Goldilocks Zone" of intervention timing to maximize patient survival and minimize complications.
Methods and Data
Researchers utilized the Clinical Data Analysis and Reporting System (CDARS) in Hong Kong, a comprehensive electronic healthcare record system, to analyze 6,474 adult patients who underwent therapeutic endoscopy within 48 hours of admission between 2013 and 2019.
To address selection bias inherent in retrospective data, the study employed Inverse Probability of Treatment Weighting (IPTW). This statistical method balances baseline characteristics—such as age, comorbidities, and initial blood pressure—across the three timing cohorts:
- Urgent: $\le$ 6 hours
- Early: 6–24 hours
- Late: 24–48 hours
Key Results
The study identified a "U-shaped" risk curve, where both intervening too early and too late increased the risk of adverse outcomes compared to the 6–24 hour "Early" window.
The Stabilization Paradox
The most significant finding was that the urgent group ($\le$ 6 hours) experienced the poorest outcomes. Rushing to the endoscopy suite may preclude adequate medical optimization; a brief period of fluid resuscitation and pharmacological therapy (e.g., proton-pump inhibitors) can stabilize the patient and clear the stomach, making the procedure safer and more effective.
Clinical Outcomes
Using the Early group (6–24 hours) as the reference point, the following results were observed:
- 30-Day Mortality: The Urgent group had a 43% higher risk of death (aHR 1.43), while the Late group had a 25% higher risk (aHR 1.25).
- Repeat Procedures: The Urgent group was 21% more likely to require a second therapeutic endoscopy, suggesting that rushed initial procedures may be less definitive.
- ICU Admissions: Urgent intervention was associated with a 40% higher rate of ICU admission compared to the early group.
Discussion and Limitations
The benefit of the 6–24 hour window was most pronounced in patients with non-variceal bleeding. For variceal bleeding, outcomes were more closely tied to the severity of underlying liver disease than to procedural timing.
Limitations of the study include its retrospective nature and the exclusion of patients who were too unstable for any procedure or those whose bleeding stopped spontaneously. Furthermore, missing admission vitals required statistical imputation. Future prospective trials are needed to determine if these timing rules apply to the most critically ill patients presenting in profound shock.
Conclusion
For patients requiring therapeutic endoscopy for AUGIB, faster is not always better. Performing the procedure in the 6–24 hour window allows for vital pre-procedural resuscitation, leading to lower mortality and fewer repeat interventions compared to urgent or late endoscopy.
Summary updated